Topics

Articles

How current frameworks influence coverage decisions and pricing negotiations.

The Evolving Value Assessment Landscape in the US

Document reveals that 20 of 28 of participating Big Pharma manufacturers saw their DIO increase by an average of 5%, suggesting that large amounts of inventory do not necessarily offer protection from running low on medication.

nVentic Report: Manufacturer Inventories Fail to Prevent Medicine Shortages

Financial commitment will allow the firm to further build upon its resources and capabilities in assisting pharma clients. 

Beghou Consulting Secures Investment from Varsity Healthcare Partners

Acquisition is expected to drive organization’s ‘next phase of growth.’

Private Investment Consortium Purchases Syneos Health for $7.1 Billion

A ‘next generation’ CRM platform will gradually leave the Salesforce.com platform behind.

Veeva Is Building Its Own Cloud Platform, Plus Other New Capabilities for Managing Life Sciences Sales and Marketing 

The deal—potentially totaling upwards of $100 million—strengthens the company’s selection of US generic prescription products.




 Dr. Reddy’s Acquires Mayne Pharma Portfolio

Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.

Jasmin Patel of a-Connect provides insight on how to navigate the ebbs and flows of employment. 




Navigating One’s Bio-Pharma Career through 2023’s Turbulent Job Markets

Expansion expected to help tackle health issues at a faster rate, company says




Lilly Financially Commits Additional $450M toward Research Triangle Park Facility

Annual report finds continuing impact of COVID-19 on global markets

Global Medicines Market to Grow 3-6% Annually to $1.9 Trillion through 2027, Says IQVIA

Partnership aims to lower prescription drug costs and increase price transparency

Business and Finance